ExploreWatchlistsPricing
  1. JP-listed companies
  2. JMS CO.,LTD.
  3. Financials
  4. Total non-current liabilities

JMS CO.,LTD. (7702)

Market cap
¥10.6B
P/E ratio
17.5x
JMS manufactures and sells medical devices and pharmaceuticals globally, serving healthcare markets across Asia, Europe and the Americas.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal non-current liabilities (Million JPY)YoY (%)
Mar 31, 202614,593-1.90%
Mar 31, 202514,875+6.02%
Mar 31, 202414,031+5.73%
Mar 31, 202313,270+10.31%
Mar 31, 202212,030+4.19%
Mar 31, 202111,546-5.37%
Mar 31, 202012,201-4.35%
Mar 31, 201912,756-13.04%
Mar 31, 201814,669+6.02%
Mar 31, 201713,836+10.49%
Mar 31, 201612,522+50.65%
Mar 31, 20158,312

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat